Form 8-K - Current report:
SEC Accession No. 0001279569-23-000960
Filing Date
2023-08-02
Accepted
2023-08-01 20:24:33
Documents
14
Period of Report
2023-08-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fourfront8k.htm   iXBRL 8-K 28615
2 NEWS RELEASE DATED AUGUST 1, 2023 ex991.htm EX-99.1 7586
3 GRAPHIC image_001.jpg GRAPHIC 8404
  Complete submission text file 0001279569-23-000960.txt   221112

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20230801.xsd EX-101.SCH 3094
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20230801_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20230801_pre.xml EX-101.PRE 22372
8 EXTRACTED XBRL INSTANCE DOCUMENT fourfront8k_htm.xml XML 3147
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 231133328
SIC: 2833 Medicinal Chemicals & Botanical Products